Prevalence and clinical relevance of serum Anti-pB3 antibodies in patientswith cholangiocarcinoma

Citation
P. Tangkijvanich et al., Prevalence and clinical relevance of serum Anti-pB3 antibodies in patientswith cholangiocarcinoma, A P J ALLER, 18(3), 2000, pp. 173-176
Citations number
29
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
ISSN journal
0125877X → ACNP
Volume
18
Issue
3
Year of publication
2000
Pages
173 - 176
Database
ISI
SICI code
0125-877X(200009)18:3<173:PACROS>2.0.ZU;2-6
Abstract
Cholangiocarcinoma (CCA) constitutes carcinoma of the bile duct found at a high prevalence in northeastern Thailand. In the present study, we examined the sera of altogether 82 Thai CCA patients for the presence of anti-p53 a ntibodies in order to investigate a role of the tumor suppressor gene, p53 in the carcinogenesis. Our results revealed anti-p53 antibodies in 7.3% of the cases tested, which conforms to the prevalence rate of p53 gene mutatio n recently reported at 5% among Thai patients. With limited number of the p atients, anti-p53 antibodies were rapidly detected more frequently among pa tients with peripheral tumors than those with central tumors. However, furt her studies is required to establish significance and prognostic value of t he antibodies in the context of CCA.